Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/18/2010WO2010042649A3 PHTHALAZINE COMPOUNDS AS p38 MAP KINASE MODULATORS AND METHODS OF USE THEREOF
11/18/2010WO2010039186A3 Benzoxazoles useful as faah modulators and uses thereof
11/18/2010WO2010036613A8 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
11/18/2010WO2010034838A3 Antiproliferative compounds
11/18/2010WO2010034670A3 Host cell kinases as targets for antiviral therapies against hcv infection
11/18/2010WO2010033543A3 Substituted benzamides as cannabinoid receptor ligands
11/18/2010WO2010033426A3 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor
11/18/2010WO2010033258A8 A novel iodinated resin manufacturing process and product
11/18/2010WO2010033168A3 Modulators of p2x3 receptor activity
11/18/2010WO2010032165A3 Prodrugs of artemisinin
11/18/2010WO2010017466A3 Phenobarbital salts; methods of making; and methods of use thereof
11/18/2010WO2010014814A8 Glycosylated warfarin analogs and uses thereof
11/18/2010WO2010000469A3 Crystalline salts of sitagliptin
11/18/2010WO2009156735A3 New therapeutic agents
11/18/2010WO2009141079A8 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (ii), use thereof and method for their production
11/18/2010WO2009140421A8 Polymeric carrier
11/18/2010WO2009126806A8 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase
11/18/2010WO2009124733A8 Substituted sulfonamide derivatives
11/18/2010WO2009039442A9 Nfia in glial fate determination, glioma therapy and astrocytoma treatment
11/18/2010WO2008148016A9 Inhibiting the signs of aging by inhibiting nf-kappa b activation
11/18/2010US20100292650 Methods and Related Compositions for Reduction of Fat and Skin Tightening
11/18/2010US20100292625 Pharmaceutical and cosmetic compositions for accelerated healing of wounds and other surface damages
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292456 Rna interference mediating small rna molecules
11/18/2010US20100292455 MODIFIED iRNA AGENTS
11/18/2010US20100292346 Stereoisomers Propofol Therapeutic Compounds
11/18/2010US20100292345 Therapeutic uses of cannabigerol
11/18/2010US20100292344 Methods and Compositions for Treating Thalamocortical Dysrhythmia
11/18/2010US20100292342 Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof
11/18/2010US20100292341 Quick dissolve compositions of memantine hydrochloride
11/18/2010US20100292340 Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine
11/18/2010US20100292339 Genetic Polymorphisms Predictive of Nutritional Requirements for Choline in Subjects
11/18/2010US20100292338 Silk medical device with antimicrobial properties and a method of manufacture thereof
11/18/2010US20100292337 Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same
11/18/2010US20100292336 Polar Hydrophilic Prodrugs and Non-Standard Amino Acid Conjugates of Amphetamine and Other Stimulants and Processes for Making and Using the Same
11/18/2010US20100292335 Use of organic compounds
11/18/2010US20100292334 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
11/18/2010US20100292333 Compositions suitable for the topical treatment of fungal infections of the skin and nails
11/18/2010US20100292332 Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine
11/18/2010US20100292331 Biomarkers for Prostate Cancer and Methods Using the Same
11/18/2010US20100292330 Compositions and methods for enhancing cognitive function
11/18/2010US20100292329 4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain
11/18/2010US20100292327 Treatment of aspirin resistance with betaine and/or betaine enriched molasses
11/18/2010US20100292326 Pharmaceutical composition comprising s-nitrosoglutathione and polysaccharide
11/18/2010US20100292325 P-menthawe-3-carboxylic acid esters to treat airways diseases
11/18/2010US20100292324 Multi-Substituted Diarylanilines as Non-Nucleoside HIV Reverse Transcriptase Inhibitors, and Preparation and Use Thereof
11/18/2010US20100292322 Bis-Platinum Complexes With Antitumor Activity
11/18/2010US20100292320 Benzofuran anilide histone deacetylase inhibitors
11/18/2010US20100292319 Process for preparing benzofurans
11/18/2010US20100292318 Antibacterial composition comprising salvia extracts
11/18/2010US20100292317 Antimicrobial and radioprotective compounds
11/18/2010US20100292316 Improved therapeutic methods and compositions comprising chroman ring compounds
11/18/2010US20100292314 Anti-angiogenic compositions and methods of use
11/18/2010US20100292313 Compositions and methods for treating ischemia and ischemia-reperfusion injury
11/18/2010US20100292312 Anti-dll4 antibodies and methods using same
11/18/2010US20100292311 Oligomeric compounds for the modulation of survivin expression
11/18/2010US20100292310 Micro-rna scaffolds and non-naturally occurring micro-rnas
11/18/2010US20100292309 Inducing immune-mediated tumor cell death
11/18/2010US20100292308 Microrna molecules
11/18/2010US20100292307 Construct
11/18/2010US20100292306 Compositions And Methods For The Treatment Of Muscular Dystrophy
11/18/2010US20100292305 RNAi MODULATION OF HIF-1 AND THERAPUTIC USES THEREOF
11/18/2010US20100292304 Compounds and methods for improving cellular uptake of oligomeric compounds
11/18/2010US20100292303 Gene expression profile for predicting ovarian cancer patient survival
11/18/2010US20100292302 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity
11/18/2010US20100292301 Novel sirna structures
11/18/2010US20100292300 Compositions and methods for inhibiting or reversing fibrotic disorders
11/18/2010US20100292299 Nucleotide Motifs Providing Localization Elements and Methods of Use
11/18/2010US20100292298 Method and reagents for treating hepatic fibrosis and inflammation
11/18/2010US20100292297 Micrornas That Regulate Muscle Cell Proliferation and Differentiation
11/18/2010US20100292296 Novel ligands that modulate rar receptors
11/18/2010US20100292295 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators
11/18/2010US20100292294 Compositions Comprising a Physiological Coolant
11/18/2010US20100292293 Therapeutic substituted lactams
11/18/2010US20100292292 Treatment of Neurodegenerative Diseases Using Indatraline Analogs
11/18/2010US20100292291 Formulations of deacetylase inhibitors
11/18/2010US20100292290 Novel process to prepare almotriptan
11/18/2010US20100292289 Treatment of metabolic syndrome with novel amides
11/18/2010US20100292288 Crystalline forms of (r)-1-{2-[4`- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto
11/18/2010US20100292287 Periodontitis treatment
11/18/2010US20100292286 Crystalline imidazole-5-carboxylic acid derivative
11/18/2010US20100292284 Talarazole metabolites
11/18/2010US20100292283 Novel phenyl-acetamide and phenyl-propionamide derivatives useful as potassium channel modulators
11/18/2010US20100292282 Synthesis and crystalline forms of cb-1 antagonist/inverse agonist
11/18/2010US20100292281 Treatment of mci and alzheimer's disease
11/18/2010US20100292280 Anti-pyretic vasodilators
11/18/2010US20100292279 Bis-(Sulfonylamino) Derivatives in Therapy
11/18/2010US20100292278 Methods of treating vascular disease and injury
11/18/2010US20100292277 Combination treatment of metabolic disorders
11/18/2010US20100292276 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010US20100292274 Haloalkyl heteroaryl benzamide compounds
11/18/2010US20100292273 Cannabinoid Receptor Modulators
11/18/2010US20100292272 Supramolecular co-colloids produced using macrocyclic polyanionic systems
11/18/2010US20100292271 Quinoline Compounds Suitable for Treating Disorders that Respond to Modulation of the Serotonin-5-HT6 Receptor
11/18/2010US20100292270 Treatment of cachexia
11/18/2010US20100292269 Bir domain binding compounds
11/18/2010US20100292268 Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use
11/18/2010US20100292267 Palonosetron free base and process for its preparation
11/18/2010US20100292266 Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase
11/18/2010US20100292265 Pack Of Medicinal Tablets
1 ... 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 ... 7860